GTHX - G1 Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.01B
Enterprise Value 3349.89M
Trailing P/E N/A
Forward P/E 1-7.18
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.97
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-3.71

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-21.57%
Return on Equity (ttm)-34.03%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-70.68M
EBITDA -94.23M
Net Income Avi to Common (ttm)-88.83M
Diluted EPS (ttm)-2.52
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)347.8M
Total Cash Per Share (mrq)9.28
Total Debt (mrq)1.55M
Total Debt/Equity (mrq)0.46
Current Ratio (mrq)30.21
Book Value Per Share (mrq)9.05

Cash Flow Statement

Operating Cash Flow (ttm)-77.74M
Levered Free Cash Flow (ttm)-48.85M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.24
52-Week Change 3-57.92%
S&P500 52-Week Change 34.18%
52 Week High 369.57
52 Week Low 313.87
50-Day Moving Average 321.11
200-Day Moving Average 320.61

Share Statistics

Avg Vol (3 month) 3377.53k
Avg Vol (10 day) 3380.92k
Shares Outstanding 537.47M
Float 27.8M
% Held by Insiders 117.81%
% Held by Institutions 189.86%
Shares Short (May 31, 2019) 43.39M
Short Ratio (May 31, 2019) 47.47
Short % of Float (May 31, 2019) 414.01%
Short % of Shares Outstanding (May 31, 2019) 49.05%
Shares Short (prior month Apr 30, 2019) 43.32M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A